HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits.

Abstract
Eighteen patients with acute optic neuritis underwent optic nerve magnetic resonance imaging (MRI) before and after injection of gadolinium-diethylene triamine pentacetic acid (Gd-DTPA). Ten were re-examined 4 weeks later. Leakage of Gd-DTPA across the blood-optic nerve barrier was a consistent finding in the acute lesion, and its presence was associated with abnormal visual acuity and colour vision, retro-ocular pain on eye movement, and afferent pupillary defect, and a reduced amplitude of the P100 component of the visual evoked potential. Gd-DTPA leakage had ceased in 9/11 nerves when restudied 4 wks later, and this evolution was associated with improved visual acuity and an increased P100 amplitude. Leakage is likely to reflect inflammation, and we conclude that the latter plays an important part in the production of conduction block and clinical deficit, and that its resolution is an important step in clinical remission from acute episodes of demyelination.
AuthorsB D Youl, G Turano, D H Miller, A D Towell, D G MacManus, S G Moore, S J Jones, G Barrett, B E Kendall, I F Moseley
JournalBrain : a journal of neurology (Brain) Vol. 114 ( Pt 6) Pg. 2437-50 (Dec 1991) ISSN: 0006-8950 [Print] England
PMID1782525 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Organometallic Compounds
  • Pentetic Acid
  • Gadolinium DTPA
Topics
  • Adolescent
  • Adult
  • Electrophysiology
  • Evoked Potentials, Visual
  • Gadolinium DTPA
  • Humans
  • Magnetic Resonance Imaging
  • Middle Aged
  • Optic Neuritis (diagnosis, physiopathology)
  • Organometallic Compounds (metabolism)
  • Pentetic Acid (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: